{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:45:54Z","timestamp":1772793954313,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Teva Pharmaceuticals"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.expneurol.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T12:45:19Z","timestamp":1465908319000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"PA","title":["Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons"],"prefix":"10.1016","volume":"283","author":[{"given":"Dagmar E.","family":"Ehrnhoefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.06.008_bb0005","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/hmg\/ddv023","article-title":"A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits","volume":"24","author":"Aharony","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0010","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1523\/JNEUROSCI.0698-11.2011","article-title":"Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon\/neuron loss and improves neurological function after stroke","volume":"31","author":"Akpan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0015","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","article-title":"Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines","volume":"20","author":"Bentires-Alj","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/ecp.12.12","article-title":"Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis","volume":"5","author":"Bruck","year":"2012","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","article-title":"Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination","volume":"124","author":"Bruck","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2011.03.018","article-title":"Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease","volume":"43","author":"Carroll","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/A:1024116916932","article-title":"Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties","volume":"8","author":"Caserta","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jclinepi.2014.08.007","article-title":"Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review","volume":"67","author":"Chen","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0045","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/ncomms2910","article-title":"Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning","volume":"4","author":"Cusack","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027680","article-title":"A quantitative method for the specific assessment of caspase-6 activity in cell culture","volume":"6","author":"Ehrnhoefer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrd3556","article-title":"Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development","volume":"10","author":"Ehrnhoefer","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/ddt458","article-title":"p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin","volume":"23","author":"Ehrnhoefer","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0065","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1074\/jbc.274.4.2225","article-title":"Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL","volume":"274","author":"Finucane","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0070","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.tins.2011.09.001","article-title":"Caspase-6 and neurodegeneration","volume":"34","author":"Graham","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0080","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awt023","article-title":"Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis","volume":"136","author":"Jolivel","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2015.16","article-title":"Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated caspase-6 activation","author":"Kaushal","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0095","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/ejn.12250","article-title":"Caspase-6 as a novel early target in the treatment of Alzheimer's disease","volume":"37","author":"LeBlanc","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0105","doi-asserted-by":"crossref","unstructured":"Matsui, J.T., Vaidya, J.G., Wassermann, D., Kim, R.E., Magnotta, V.A., Johnson, H.J., Paulsen, J.S., Investigators, P.-H., Coordinators of the Huntington Study, G., 2015. Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum. Brain Mapp.","DOI":"10.1002\/hbm.22835"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acn3.67","article-title":"Laquinimod reduces neuroaxonal injury through inhibiting microglial activation","volume":"1","author":"Mishra","year":"2014","journal-title":"Ann. Clin. Biochem. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/srep00225","article-title":"NMDA receptors and BAX are essential for Abeta impairment of LTP","volume":"2","author":"Olsen","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0120","doi-asserted-by":"crossref","first-page":"16443","DOI":"10.1074\/jbc.271.28.16443","article-title":"The CED-3\/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A","volume":"271","author":"Orth","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0125","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1128\/MCB.14.10.6570","article-title":"An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation","volume":"14","author":"Perkins","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","article-title":"Longitudinal change in white matter microstructure in Huntington's disease: the IMAGE-HD study","volume":"74","author":"Poudel","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cdd.4400562","article-title":"The activity of the murine Bax promoter is regulated by Sp1\/3 and E-box binding proteins but not by p53","volume":"6","author":"Schmidt","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0140","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2002.00880.x","article-title":"NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis","volume":"81","author":"Shou","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0145","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0150","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2005.02.192","article-title":"Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated","volume":"23","author":"Starczynski","year":"2005","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw122","article-title":"Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease","author":"Teo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0160","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajpath.2011.09.037","article-title":"Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor","volume":"180","author":"Thone","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington's disease immune dysfunction caused by NFkappaB pathway dysregulation","volume":"137","author":"Trager","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0175","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/hmg\/dds005","article-title":"Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice","volume":"21","author":"Uribe","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cdd.2012.98","article-title":"Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6","volume":"20","author":"van Raam","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0185","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2010.07.009","article-title":"Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis","volume":"227","author":"Wegner","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0195","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: what's in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2014.12.030","article-title":"Partial rescue of some features of Huntington disease in the genetic absence of caspase-6 in YAC128 mice","volume":"76","author":"Wong","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.06.008_bb0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1097-2765(01)00213-1","article-title":"PUMA induces the rapid apoptosis of colorectal cancer cells","volume":"7","author":"Yu","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2016.06.008_bb0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","article-title":"Huntington's disease","volume":"220","author":"Zuccato","year":"2014","journal-title":"Handb. Exp. Pharmacol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616301741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616301741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T14:54:13Z","timestamp":1617461653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616301741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":43,"alternative-id":["S0014488616301741"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.008","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}